Literature DB >> 6166255

Antiperinuclear factor and keratin antibodies in rheumatoid arthritis.

G D Johnson, A Carvalho, E J Holborow, D H Goddard, G Russell.   

Abstract

Tests for antiperinuclear factor (APF) demonstrable by indirect immunofluorescence (IF) on smears of human buccal mucosal cells and for antibodies to keratin (AKA) detected on cryostat sections of rat oesophagus were performed on serum from 102 cases of rheumatoid arthritis (RA) and 117 controls. APF was detected in 92% of the cases of RA; positive tests obtained with non-RA sera were generally weaker than those given by the RA group, and the antibody in both RA and non-RA serum was predominantly IgG class. The difficulty in obtaining suitable substrate material previously reported was confirmed, and only 2 satisfactory donors were identified among 27 individuals tested. The incidence of keratin antibodies detected was found to be related to the site from which the tissue was taken; low oesophagus provided the best discrimination between RA and controls (51% and 5% positive respectively), and cardia of the stomach gave the highest incidence of staining in all groups. A laminar staining pattern was seen with most positive sera, but occasionally the keratinised layer was diffusely stained. The presence of AKA showed a marked correlation with both IgM rheumatoid factor and increased Clq binding in RA, but APF did not.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166255      PMCID: PMC1000759          DOI: 10.1136/ard.40.3.263

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

1.  A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

Authors:  R L NIENHUIS; E MANDEMA
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

2.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors:  C M PLOTZ; J M SINGER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

3.  Multispot immunofluorescence: a simple semi-automatic method of processing large numbers of tests.

Authors:  P O'Neill; G D Johnson
Journal:  J Clin Pathol       Date:  1970-03       Impact factor: 3.411

4.  Anti-keratin antibodies in rheumatoid arthritis.

Authors:  B J Young; R K Mallya; R D Leslie; C J Clark; T J Hamblin
Journal:  Br Med J       Date:  1979-07-14

5.  The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.

Authors:  I R Sondag-Tschroots; C Aaij; J W Smit; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

  5 in total
  23 in total

1.  Antiperinuclear factor in juvenile rheumatoid arthritis.

Authors:  G Nesher; T L Moore; M W Grisanti; E el-Najdawi; T G Osborn
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  The rheumatoid arthritis-associated autoantibodies to filaggrin label the fibrous matrix of the cornified cells but not the profilaggrin-containing keratohyalin granules in human epidermis.

Authors:  M Simon; C Vincent; M Haftek; E Girbal; M Sebbag; V Gomès-Daudrix; G Serre
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

3.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

Authors:  M Simon; E Girbal; M Sebbag; V Gomès-Daudrix; C Vincent; G Salama; G Serre
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Normal human epidermal keratinocytes express in vitro specific molecular forms of (pro)filaggrin recognized by rheumatoid arthritis-associated antifilaggrin autoantibodies.

Authors:  E Girbal-Neuhauser; M Montézin; F Croute; M Sebbag; M Simon; J J Durieux; G Serre
Journal:  Mol Med       Date:  1997-02       Impact factor: 6.354

6.  Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.

Authors:  L Vasiliauskiene; A Wiik; M Høier-Madsen
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

7.  Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.

Authors:  R L Rubin; R S Balderas; E M Tan; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

8.  Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.

Authors:  C Gabay; A M Prieur; O Meyer
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

9.  Evidence for relationships between antiperinuclear and IgG rheumatoid factor.

Authors:  P Youinou; P Le Goff; R Casburn-Budd; C Ferec; Y Pennec
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

10.  Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis.

Authors:  D L Scott; J P Delamere; L J Jones; K W Walton
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.